Screening for type 1 diabetes genetic risk in newborns of continental Italy. Primary prevention (Prevefin Italy)--preliminary data

Acta Biomed. 2005:76 Suppl 3:31-5.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Lecture
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoantibodies / blood
  • Autoantigens / immunology
  • Breast Feeding
  • Caseins / administration & dosage
  • Caseins / immunology
  • Cattle
  • Celiac Disease / blood
  • Celiac Disease / immunology
  • Celiac Disease / prevention & control
  • Contraindications
  • Diabetes Mellitus, Type 1 / diet therapy
  • Diabetes Mellitus, Type 1 / epidemiology
  • Diabetes Mellitus, Type 1 / genetics
  • Diabetes Mellitus, Type 1 / prevention & control*
  • Environmental Exposure
  • Female
  • Genetic Markers
  • Genetic Predisposition to Disease
  • Genetic Testing*
  • Genotype
  • HLA-D Antigens / genetics
  • Humans
  • Incidence
  • Infant Food* / adverse effects
  • Infant Formula
  • Infant, Newborn
  • Islets of Langerhans / immunology
  • Italy / epidemiology
  • Male
  • Milk Proteins / adverse effects
  • Molecular Mimicry
  • Neonatal Screening*
  • Patient Acceptance of Health Care
  • Vitamin D / therapeutic use*
  • Vitamin D Deficiency / complications
  • Vitamin D Deficiency / drug therapy
  • Vitamin D Deficiency / prevention & control

Substances

  • Autoantibodies
  • Autoantigens
  • Caseins
  • Genetic Markers
  • HLA-D Antigens
  • Milk Proteins
  • Vitamin D
  • casein hydrolysate